Cm Management, LLC Paratek Pharmaceuticals, Inc. Transaction History

Cm Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$1.52 - $2.8 $304,000 - $560,000	-200,000 Reduced 44.44%	250,000 $553,000
Q1 2023 May 08, 2023	BUY	$1.37 - $2.54 $143,850 - $266,700	105,000 Added 30.43%	450,000 $1.14 Million
Q4 2022 Feb 09, 2023	SELL	$1.67 - $2.51 $91,850 - $138,050	-55,000 Reduced 13.75%	345,000 $645,000
Q3 2022 Nov 04, 2022	BUY	$1.96 - $2.93 $98,000 - $146,500	50,000 Added 14.29%	400,000 $1.03 Million
Q1 2022 May 09, 2022	BUY	$2.94 - $4.77 $147,000 - $238,499	50,000 Added 16.67%	350,000 $1.04 Million
Q4 2021 Feb 02, 2022	BUY	$4.07 - $5.3 $407,000 - $530,000	100,000 Added 50.0%	300,000 $1.35 Million
Q3 2021 Nov 08, 2021	BUY	$4.7 - $7.24 $117,500 - $181,000	25,000 Added 14.29%	200,000 $972,000
Q2 2021 Aug 10, 2021	BUY	$6.81 - $10.93 $170,250 - $273,250	25,000 Added 16.67%	175,000 $1.19 Million
Q1 2021 May 12, 2021	BUY	$6.14 - $8.31 $706,100 - $955,650	115,000 Added 328.57%	150,000 $1.06 Million
Q4 2020 Feb 04, 2021	BUY	$4.58 - $7.14 $160,300 - $249,900	35,000 New	35,000 $219,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.